QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 26.60

+9.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Howard Schellenberg who wrote (525)	3/24/1997 8:42:00 AM
From: Robert Busse	of 1693

I saw that SKB's FlexSure HP test received a CLIA waiver. Actually, this is the 3rd company to receive a CLIA waiver on an H.pylori test. As I understand, QDEL was the first and some other company (quite small and whose name I do not remember) received the 2nd. SmithKline's Flexsure may be a formidable competitor with a lot of marketing muscle but I think the QDEL test still has some advantages- the SKB Flexsure test is actually a 3 step test w/ a room temperature shelf storage life of 30 days according to the press release- I'm not sure about Qdel's shelf life but I think it is substantially longer than 30 days - also Qdel test is a 1 step, not a 3 step, test. Qdel also has P+G to help promote it. This is a big and growing market and , in any event, I suspect both QDEL and FlexSure will do quite well

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next